Abstract
Favorable Outcomes of Patients with Limited-Stage Ocular Adnexal DLBCL Treated in the Rituximab Era: Long-Term Follow-up of a Single Center Experience
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have